Following the same VEGF-D induction protocol, we previously demonstrated the Adipo-VD mice are protected from obesity's metabolic syndrome, with improved glucose handling and reduced liver lipid deposition (Chakraborty et al., 2019). This evidence concerns the gene VEGFD and obesity due to melanocortin 4 receptor deficiency.